According to data from MarketBeat, Gilead Sciences currently has a consensus rating of “Moderate Buy” and a consensus price target of $86.

Source: https://www.americanbankingnews.com/2023/01/09/3600-shares-in-gilead-sciences-inc-nasdaqgild-purchased-by-alta-advisers-ltd.html

After a somewhat mixed third quarter, and shares having seen a modest decline since August, I like the appeal of Gilead here a bit more at these lower levels, making me a further buyer of today's dip.

Source: https://seekingalpha.com/article/4651136-gilead-sciences-slow-progress-but-progress-altogether?source=feed_all_articles

Archford Capital Strategies LLC’s holdings in Gilead Sciences were worth $683,000 at the end of the most recent quarter.

Source: https://www.americanbankingnews.com/2023/06/29/archford-capital-strategies-llc-acquires-145-shares-of-gilead-sciences-inc-nasdaqgild.html

Bank Julius Baer & Co. Ltd Zurich’s holdings in Gilead Sciences were worth $31,530,000 as of its most recent SEC filing.

Source: https://www.americanbankingnews.com/2023/04/02/bank-julius-baer-co-ltd-zurich-has-31-53-million-stock-holdings-in-gilead-sciences-inc-nasdaqgild.html

Beacon Investment Advisory Services Inc. cut its holdings in Gilead Sciences, Inc. () by 0.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission.

Source: https://www.etfdailynews.com/2023/10/03/beacon-investment-advisory-services-inc-has-5-70-million-holdings-in-gilead-sciences-inc-nasdaqgild/

Both Cardington and Mount Gilead will also open at home in Division III.

Source: https://www.morrowcountysentinel.com/2023/05/08/tournament-draws-announced-for-baseball/

Concord Wealth Partners acquired a new stake in Gilead Sciences during the 4th quarter worth approximately $33,000.

Source: https://www.etfdailynews.com/2023/06/24/massmutual-trust-co-fsb-adv-boosts-stake-in-gilead-sciences-inc-nasdaqgild/

Concord Wealth Partners acquired a new stake in Gilead Sciences in the fourth quarter worth $33,000.

Source: https://www.etfdailynews.com/2023/06/18/st-germain-d-j-co-inc-has-29000-position-in-gilead-sciences-inc-nasdaqgild/

Finally, Cowen lifted their price objective on Gilead Sciences from $90.00 to $95.00 in a research report on Friday, February 10th.

Source: https://www.etfdailynews.com/2023/04/01/meag-munich-ergo-kapitalanlagegesellschaft-mbh-buys-18554-shares-of-gilead-sciences-inc-nasdaqgild/

Finally, Ergoteles LLC bought a new position in shares of Gilead Sciences during the 1st quarter worth approximately $2,304,000.

Source: https://www.dailypolitical.com/2023/01/23/gilead-sciences-inc-nasdaqgild-sees-significant-increase-in-short-interest.html

Finally, JFS Wealth Advisors LLC raised its holdings in shares of Gilead Sciences by 68.1% during the third quarter.

Source: https://www.americanbankingnews.com/2023/04/08/2908-shares-in-gilead-sciences-inc-nasdaqgild-bought-by-girard-partners-ltd.html

Finally, Oppenheimer increased their price objective on Gilead Sciences from $95.00 to $105.00 in a report on Thursday, December 1st.

Source: https://www.americanbankingnews.com/2023/02/04/gilead-sciences-nasdaqgild-releases-fy23-earnings-guidance.html

Finally, started coverage on shares of Gilead Sciences in a research note on Thursday, March 16th.

Source: https://www.americanbankingnews.com/2023/05/14/eversource-wealth-advisors-llc-sells-586-shares-of-gilead-sciences-inc-nasdaqgild.html

For Gilead Christian, Seraiah Campbell placed 10th in 21:51.81.

Source: https://www.morrowcountysentinel.com/2023/10/04/northmor-xc-teams-second-at-crestline/

Gilead Sciences has a 52 week low of $57.17 and a 52 week high of $89.74.

Source: https://www.americanbankingnews.com/2023/02/04/gilead-sciences-nasdaqgild-releases-fy23-earnings-guidance.html

Gilead Sciences’s revenue was up 5.4% compared to the same quarter last year.

Source: https://www.etfdailynews.com/2023/08/28/gilead-sciences-inc-nasdaqgild-receives-consensus-rating-of-moderate-buy-from-analysts-2/

In my opinion, Gilead Sciences should be able to grow at least in the mid-single digits in the years to come.

Source: https://seekingalpha.com/article/4571511-gilead-sciences-stock-potential-to-continue-upward-trend?source=feed_all_articles

In other Gilead Sciences news, CFO sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 17th.

Source: https://www.americanbankingnews.com/2023/12/14/gilead-sciences-inc-nasdaqgild-shares-purchased-by-vicus-capital.html

In the meantime, it's a good time to review all the rules that keep Gilead afloat.

Source: https://collider.com/handmaids-tale-gilead-society-rules/

Meanwhile, Gilead won huge antitrust trial last month when A jury decided that the drug company competing HIV drugs from entering the market.

Source: https://www.lawsuit-information-center.com/truvada-lawsuit.html